VGM-R02b

N/A

Report date: 2024/06/03 16:43:51

Base Information

Drug NameVGM-R02b
Drug Alias NameAdeno-associated viral vector 9 delivering human Glutaryl-CoA Dehydrogenase (GCDH) gene (Shanghai Vitalgen BioPharma)AAV9-delivering human Glutaryl-CoA Dehydrogenase (GCDH) gene (Shanghai Vitalgen BioPharma)VGM-R02bVGM-R02
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGlutaryl-CoA Dehydrogenase agonists
TargetsGlutaryl-CoA Dehydrogenase
Therapy Area/IndicationsGlutaric Acidemia I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Vitalgen BioPharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Vitalgen BioPharma Co Ltd
Inactive CompaniesN/A
Active IndicationsGlutaric Acidemia I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A